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Sudden sensorineural hearing loss (SSNHL) is a debilitating condition with an incidence of nearly 20 per 100,000 in
populations. Metronidazole-induced ototoxicity is an extremely rare etiology of SSNHL. In this report, we describe a
young female with bilateral SSNHL due to oral use of metronidazole. A 23 years old female presented to the emergency
department with acute bilateral hearing loss. We found out that her hearing loss had started 4 days after initiation of
metronidazole which was administered for treatment of diarrhea. This case report shows that physicians should be
aware of the uncommon side effects while prescribing metronidazole to patients in order to manage the possible
adverse events on time.
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Sudden sensorineural hearing loss (SSNHL) is a subset
of sudden hearing loss (SHL) which affects nearly to 20
per 100,000 in populations [1]. Due to its debilitating na-
ture and sudden course, patients often immediately seek
medical care. If SSNHL is diagnosed and managed on
time, chance of hearing recovery as well as patient qual-
ity of life will be increased. For diagnosis of SSNHL,
hearing impairment should have rapid onset, occurring
over a 72-hour period, and a reduction in hearing of ≥30
decibels (dB) and at least 3 successive audiometric fre-
quencies should be present in the audiometric test.
Based on the latest clinical practice guidelines, comput-
erized tomography should not be ordered in the initial
evaluation of these patients [2]. Although SSNHL has a
very long list of etiologies, the etiology remains un-
known in nearly 90% of cases despite thorough evalu-
ation [3]. Thus, due to uncertain etiology in most cases,
treatment of SSNHL is mainly empiric and usually
consists of corticosteroids, [4] antivirals, antibiotics,
diuretics and mineral supplements [4,5]. Also, if a poten-
tial drug is suspected to cause SSNHL, it must be
stopped promptly.* Correspondence: s.akhond@neda.net
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A 23 years old female presented to the emergency de-
partment with acute bilateral hearing loss. Her problem
had first started 3 days ago by hearing a non-pulsatile
sound and tinnitus in both ears. Her hearing had been
progressively decreasing and worsened markedly within
the next 3 days. She denied any ear pain and drainage,
headache, vertigo or oral lesion and did not have fever
and chills. There was no history of antecedent fluctuat-
ing hearing loss, head trauma, acoustic trauma, allergic
rhinitis, sinusitis or recurrent urinary tract infection. She
reported acute watery diarrhea in the past week. She had
history of a rhinoplasty surgery 9 months previously. Ini-
tial history revealed no regular medication use. The pa-
tient did not smoke and did not use alcohol or illicit
substances.
The patient was alert and nervous. She could not hear
verbal communication clearly, thus the physician used
handwritten notes to communicate with the patient and
vice versa. Her vitals were as follows: body temperature
was 37.4°C, blood pressure was 110/65 mm Hg, heart
rate was 100 beats per minute, and her respiratory rate
was 18 breaths per minute. General physical examin-
ation was normal except for mild tenderness of both feet
to light touch. The otoscopic examination of both ear
canals and tympanic membranes were normal. Thered. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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on both sides. A complete neurologic examination was
done and was normal.
The patient was admitted to the ear, nose and throat
ward with impression of sudden bilateral sensorineural
hearing loss ematologic lab tests and biochemistry were
done and all parameters were in normal range. She was
negative for rheumatoid factor and had normal erythro-
cyte sedimentation rate (ESR) and C-reactive protein
(CRP) levels. Audiometry of both ears confirmed SNHL
(30-dB hearing loss at 3 consecutive frequencies).
The initial empiric treatment was started immediately
and included: bilateral intratympanic dexamethasone,
oral prednisolone and oral acyclovir. There was no sig-
nificant improvement by day 4 of admission. Due to in-
creased foot pain and tenderness, the patient was
admitted to the rheumatology ward for further investiga-
tion. Serologic studies for known autoimmune diseases
were normal and viral markers were negative. Metho-
trexate, pentoxifylline and folic acid were added to the
aforementioned treatment regimen. Ten days after treat-
ment initiation, gradual improvement of hearing was re-
ported by the patient. Also, serial audiogram at 10th day
showed significant improvement especially in the right
ear at low frequencies.
We continued to search for the etiology of SSNHL in
the patient by interviewing her and reviewing the history
several times on different occasions. Serendipitously, we
found out that her hearing loss had started 4 days after
initiation of metronidazole which was administered for
treatment of diarrhea.
Discussion
In this report we present an extremely rare etiology of
bilateral SSNHL. There are only three metronidazole-
associated SSNHL reports in the literature [6]. Metronida-
zole is a 5-nitromidazole antibiotic which is widely used
against anaerobic bacteria and protozoal infections. In
general, metronidazole has a relatively safe drug profile
and is well tolerated but there are several reports that high
doses or prolonged administration can on rare occasions
cause serious adverse events. Different mechanisms have
been suggested for metronidazole-induced neurotoxicity
including inhibition of protein synthesis, vasogenic and
cytotoxic edema and mitochondrial dysfunction. To date,
the exact mechanism still remains unknown. Interestingly
it has been reported that metronidazole can augment
gentamycin-induced ototoxicity [7].
The patient described in this report presented to the
Emergency Department with bilateral SHL. Audiogram
confirmed the diagnosis of SSNHL. Despite complete
physical examination and laboratory studies, the under-
lying cause remained unknown until we interviewed the
patient several times and discovered metronidazole use.Early treatment and supportive care eventually reversed
the SNHL although not completely. After 2 weeks of
hospitalization, she was eventually discharged with oral
folic acid, pentoxifyllin and calcium supplements.
Recently a systematic review found no association be-
tween dose or duration of metronidazole use and rare
side effects [8]. In our patient, metronidazole was ad-
ministered 750 mg orally 3 times daily for 10 days for
treatment of symptomatic Blastocystis Hominis infec-
tion. She noted that as the diarrhea and GI symptoms
resolved on the 4th day of the treatment, she discontin-
ued the drug. Although this is the recommended dose
by Center for Disease Control for treatment of Blasto-
cystis infection and the patient did not complete treat-
ment for the prescribed duration, she experienced
bilateral SSNHL 96-hours after the treatment was
commenced.
Conclusion
Taken all together, this case suggests that physicians
should be aware of the uncommon side effects while
prescribing metronidazole to patients in order to man-
age the possible adverse events on time.
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